12 Health Care Stocks Moving In Wednesday's Pre-Market Session

Loading...
Loading...

 

Gainers

  • Genocea Biosciences GNCA shares moved upwards by 70.9% to $0.1 during Wednesday's pre-market session. The market value of their outstanding shares is at $6.1 million.
  • Motus GI Hldgs MOTS shares rose 32.85% to $0.34. The market value of their outstanding shares is at $18.8 million.
  • Cingulate CING stock increased by 15.04% to $1.3. The market value of their outstanding shares is at $14.7 million.
  • AcelRx Pharmaceuticals ACRX shares increased by 12.2% to $0.25. The company's market cap stands at $36.7 million.
  • Aprea Therapeutics APRE shares moved upwards by 10.71% to $0.74. The company's market cap stands at $16.2 million.
  • Vallon Pharmaceuticals VLON shares moved upwards by 10.55% to $0.57. The market value of their outstanding shares is at $5.9 million.

Losers

  • Verrica Pharmaceuticals VRCA stock declined by 54.9% to $2.51 during Wednesday's pre-market session. The company's market cap stands at $69.0 million.
  • Roivant Sciences ROIV stock decreased by 13.3% to $3.39. The market value of their outstanding shares is at $2.3 billion.
  • NexGel NXGL stock fell 12.86% to $1.22. The market value of their outstanding shares is at $6.7 million.
  • Better Therapeutics BTTX stock fell 12.33% to $1.92. The market value of their outstanding shares is at $45.3 million.
  • BIMI Intl Medical BIMI shares declined by 10.98% to $0.56. The company's market cap stands at $5.7 million. As per the press release, Q1 earnings came out 3 days ago.
  • Soligenix SNGX stock decreased by 10.49% to $0.51. The market value of their outstanding shares is at $21.9 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Posted In: Pre-Market OutlookMarketsMoversBZI-TFM
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...